UK NHS Adopts AI Virtual Care to Manage 7.25 Million Waiting List, Doccla Platform Achieves 39% Reduction in Non-Elective Admissions
The UK National Health Service (NHS) is introducing AI-driven virtual care technology to cope with m...
Serbia's Vinca Institute Signs Isotope Supply Contract with Russian Enterprise
The Vinča Institute of Nuclear Sciences in Serbia has signed a radioactive isotope supply contract w...
Stäubli Switzerland Officially Launches the TX2-60L MedX Ready Six-Axis Medical Robot
Stäubli Robotics recently launched a six-axis high-precision robot named TX2-60L MedX Ready, primari...
U.S.-based Toothsure to Invest in Manufacturing Plant in Perry County, Kentucky
U.S. oral medical device manufacturer Toothsure has announced it will build a new manufacturing faci...
China's BAAI Releases BAAI Cardiac Agent, Boosting Cardiac MRI Diagnostic Efficiency by 30 Times and Fully Open-Sourcing It
On May 6, 2026, the Beijing Academy of Artificial Intelligence (BAAI), in collaboration with Beijing...
China's Insilico Medicine Releases LabClaw Intelligent Lab System, Five AI Agents Synergistically Drive a 5.7-Fold Increase in Drug R&D Efficiency
Chinese AI pharmaceutical company Insilico Medicine officially released its next-generation intellig...
LightForce Launches Patient-Specific 3D-Printed Metal Brackets in the U.S.
Orthodontic company LightForce Orthodontics has launched a metal bracket called LightBracket Metal i...
Insilico Medicine's Inhaled Solution Receives Clinical Trial Approval from China's CDE
Insilico Medicine recently announced that its drug candidate, Rentosertib Inhalation Solution, has r...
Samsung Bioepis Partners with ATLATL to Accelerate Biotech Incubation in Asia-Pacific
Samsung Bioepis Co., Ltd. and ATLATL Innovation Center recently announced the signing of a Memorandu...
India's Sun Pharma to Acquire Organon for $11.75 Billion
India's Sun Pharmaceutical Industries Ltd. announced it will acquire U.S.-based Organon in an all-ca...
Pulsed Field Ablation for Atrial Fibrillation Trial Reveals Elevated Stroke Risk
The AVANT GUARD trial, comparing pulsed field ablation (PFA) with antiarrhythmic drugs (AAD) in pati...
U.S. Serif Launches Modified DNA Therapy with $50M Funding from Flagship Pioneering
U.S. startup Serif Biomedicines has recently emerged from stealth mode, introducing a novel therapeu...
Abbott's AI Coronary Imaging Platform Ultreon 3.0 Receives US and EU Approval
Abbott announced that its next-generation coronary imaging platform, Ultreon 3.0, has received FDA a...
New CPT Codes Facilitate Implementation of AI Coronary Artery Plaque Analysis
Using artificial intelligence (AI) for coronary artery plaque analysis has become an important trend...
Samsung Bioepis and ATLATL Collaborate to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
Samsung Bioepis Co., Ltd. and ATLATL Innovation Centre, a global life science R&D innovation platfor...
Clinical Trial Pharmacy Software Drives Digital Transformation in Drug Development
The pharmaceutical and biotechnology industry is undergoing a major transformation in clinical trial...
Solengepras improves non-motor symptoms in Parkinson's disease
Solengepras has shown early potential in treating Parkinson's disease (PD), particularly targeting o...
IMG Pharma Acquires Japan's Matsumoto Pharmaceutical to Strengthen Integrated Healthcare Platform
IMG Pharma Co., Ltd. (IMG Pharma), based in Tokyo, Japan, announced that it has reached a definitive...
Xcovery Partners with EVERSANA to Expand Launch of ALK-Positive Lung Cancer Drug
Xcovery Holdings has entered into a collaboration agreement with commercialization services provider...
BD and Suttons Creek Partner to Advance Combination Product Development
Becton, Dickinson and Company (BD) and Suttons Creek, a BlueRidge Life Sciences company, have announ...
MIT's Self-Organizing Pencil Beam Laser Boosts Biological Imaging Speed by 25 Times
Researchers at the Massachusetts Institute of Technology have discovered an optical self-organizatio...
US Digital Health Company Profusa Plans to Acquire Multi-Omics Precision Diagnostics Platform for $30 Million
Profusa, a Nasdaq-listed company headquartered in Berkeley, California, announced that it has signed...
U.S. FDA Approves Allevion Medical's Minimally Invasive Surgical System
The U.S. Food and Drug Administration (FDA) recently approved Allevion Medical's Vantage system, whi...
Rising Incidence of Radiation Therapy-Related Acute Myeloid Leukemia
New population-based study data from the Osaka International Cancer Institute in Japan shows that al...
IDEAYA Biosciences Initiates Clinical Trial for New Drug to Address Solid Tumors and Cancer Drug Resistance
IDEAYA Biosciences, Inc., a precision medicine oncology company in the United States, announced that...
World's First! China's Radiomedicine's Nuclear Drug 99mTc-3PRGD2 Broad-Spectrum Tumor Imaging Agent Approved for Market Launch
On April 2, 2026, the China National Medical Products Administration approved the market launch of T...
U.S. Azurity Pharmaceuticals Launches New Oral Solution for Treating Attention Deficit Hyperactivity Disorder
Azurity Pharmaceuticals, Inc., a company dedicated to providing innovative pharmaceutical solutions ...
Christ Hospital Launches AI Virtual Assistant for Heart Failure Patient Care
On April 2, 2026, a pilot randomized controlled trial showed that an AI virtual assistant designed f...
GEA and Hovione Collaborate to Launch Solution Accelerating Smart Tablet Manufacturing Development
German company GEA and Portuguese firm Hovione have joined forces to launch the SimpleCT solution, a...
$400 Million to Buy a "Pharmaceutical Brain": Anthropic Makes Its First Acquisition of AI Biotech Company Coefficient Bio
Claude's parent company has started buying "pharmaceutical brains." Anthropic has acquired AI biotec...